KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM
KS01.6.A UCPVAX-GLIO:一项评估抗端粒酶疫苗在初诊胶质母细胞瘤患者中免疫原性和疗效的II期临床试验
期刊:Endocrine-Related Cancer
影响因子:4.6
doi:10.1530/ERC-13-0470
Ware, Kathryn E; Garcia-Blanco, Mariano A; Armstrong, Andrew J; Dehm, Scott M; Carpentier, A F; Verlut, C; Ghiringhelli, F; Bronnimann, C; Ursu, R; Fumet, J; Gherga, E; Lefort, F; Belin, C; Vernerey, D; Mathieu Larroquette, M; Hervieu, A; Laheurte, C; Meurisse, A; Jacquin, M; Malfroy, M; Kroemer, M; Clairet, A; Fagnoni-Legat, C; Lehmann-Che, J; Boullerot, L; Cuzzubbo, s; Adotevi, O